The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...
Product list 1 - 50:
| S.No | Compound Name | CAS | Remarks |
|---|---|---|---|
| 1 | 1-(9H-Carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy) ethyl amino] propan-2-ol | 72956-09-3 | Carvedilol WS |
| 2 | 4-(Oxiran-2-ylmethoxy)-9H-carbazole | 51997-51-4 | Carvedilol EP Impurity D; Carvedilol USP-D |
| 3 | 1-(9H-Carbazol-4-yloxy)-3-[2-(2-methoxy phenoxy)ethyl-propan-2-ylamino]propan-2-ol | 1246819-01-1 | N-Isopropyl Carvedilol |
| 4 | 2-(2-Methoxyphenoxy) ethanamine | 1836-62-0 | Carvedilol related compound E |
| 5 | 1-[4-[2-Hydroxy-3-[2-(2-methoxyphenoxy) ethylamino] propoxy]crarbazol-9-yl]-3-[2-(2-methoxyphenoxy) ethylamino] propan-2-ol | 1198090-73-1 | Carvedilol USP-A, Carvedilol EP Impurity A |
| 6 | 1-(9H-Carbazol-4-yloxy)-3-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-[2-(2-methoxyphenoxy) ethyl] amino] propan-2-ol | 918903-20-5 | Carvedilol USP-B, Carvedilol EP Impurity B |
| 7 | 1-[Benzyl-[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol | 72955-94-3 | Carvedilol EP Impurity C; Carvedilol USP-C |
| 8 | 1-[9-[3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]carbazol-4-yl]oxy-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol | 1391052-16-6 | Carvedilol EP Impurity D |
| 9 | 1-(9H-Carbazol-4-yloxy)-3-[2-[2-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy] phenoxy]ethylamino]propan-2-ol | 1346602-98-9 | Carvedilol Bisalkyl pyrocatechol Impurity |
| 10 | 2-[2-(Cyano methoxy)phenoxy]acetonitrile | 27165-64-6 | Carvedilol impurity 16 |
| 11 | 2-(5-Methoxy-1H-indol-3-yl) ethanamine; hydrochloride | 66-83-1 | Melatonin Related compound |
| 12 | N-[3-(2-Formamido-5-methoxyphenyl)-3-oxopropyl] acetamide | 52450-38-1 | Melatonin degradant |
| 13 | 4-Ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl) carbamoyl sulfamoyl] phenyl] ethyl]-5-oxo-2H-pyrrole-1-carboxamide | 684286-46-2 | Glimepiride EP Impurity A; Glimepiride USP-A |
| 14 | 4-ethyl-3-methyl-5-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-pyrrole-1-carboxamide | 119018-29-0 | Glimepiride EP Impurity B;Glimepiride USP-B |
| 15 | Methyl N-[4-[2-[(4-ethyl-3-methyl-5-oxo-2H-pyrrole-1-carbonyl)amino]ethyl]phenyl]sulfonyl carbamate | 119018-30-3 | Glimepiride EP Impurity C;Glimepiride USP-C |
| 16 | 4-Ethyl-3-methyl-N-[2-[3-[(4-methylcyclohexyl) carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide | 791104-62-6 | Glimepiride EP Impurity D;Glimepiride USP-D |
| 17 | (2R,3S)-5-[3-(tert-Butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol | 42200-33-9 | Nadolol WS |
| 18 | cis-5-[(2RS)-2,3-Dihydroxypropoxy]-1,2,3,4-tetrahydronaphtalene-2,3-diol | NA | Nadolol EP Impurity A; Nadolol alcohol (USP) |
| 19 | cis-5-[(2RS)-2-Hydroxy-3-methoxypropoxy]-1,2,3,4-tetrahydronaphtalene-2,3-diol | NA | Nadolol EP Impurity B; Nadolol Methoxy analog (USP) |
| 20 | 5,5'-[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(cis-1,2,3,4-tetrahydronaphthalene-2,3-diol) | NA | Nadolol EP Impurity C; Diaryl glycerol analog(USP) |
| 21 | 5,5' [[(1,1-Dimethylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy]]bis(cis-1,2,3,4-tetrahydronaphthalene-2,3-diol) | 67247-26-1 | Nadolol EP Impurity D; Nadolol dimer (USP) |
| 22 | cis-5-[(2-RS)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-8-iodo-1,2,3,4-tetrahydronaphtalene-2,3-diol | 67247-33-0 | Nadolol EP Impurity E |
| 23 | 1-(tert-Butylamino)-3-naphthalen-1-yloxypropan-2-ol | 2116-22-5 | Nadolol EP Impurity F; Naphthyl analoge(USP) |
| 24 | 1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol | 33841-03-1 | Nadolol EP Impurity G; Dideoxy Nadolol (USP) |
| 25 | 5-(2-Bromoethyl)-2,3-dihydro-1-benzofuran | 127264-14-6 | Darifenacin related compound |
| 26 | 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetonitrile;hydrobromide | 194602-27-2 | Darifenacin related compound |
| 27 | (2R,3R)-2,3-Dihydroxybutanedioic acid;2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide | 134002-26-9 | Darifenacin related compound |
| 28 | (S)-2-{1-[3-(2-Bromoethyl)-4-hydroxyphenethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide | 2468796-89-4 | Darifenacin related compound |
| 29 | (S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenyl-N-[2-(2,3-dihydrobenzfuran-5-yl)ethyl]acetamide hydrobromide | 2280857-32-9(free base) | Darifenacin Dimer-2 Impurity |
| 30 | (S)3-(2-Amino-2-oxo-1,1-diphenylethyl)-1,1-bis(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-1-ium bromide | NA | Darifenacin Pyrrolidinium Dimer Impurity |
| 31 | Methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate | 59122-46-2 | Misoprostol WS |
| 32 | Methyl 7-[(1R,2S)-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate | 58682-86-3 | Misoprostol EP Impurity C |
| 33 | Methyl 7-[2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopenten-1-yl]heptanoate | 1331639-92-9 | Misoprostol EP Impurity D |
| 34 | Methyl (1S*,2R*,3R*)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-1-octenyl]-5-oxocyclopentane-heptanoate | 1788085-78-8 | Misoprostol EP Impurity A; 8-epi-Misoprostol |
| 35 | Methyl (1S*,2R*,3S*)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-1-octenyl]-5-oxocyclopentane-heptanoate | NA | Misoprostol EP Impurity B; 12-epi-Misoprostol |
| 36 | Methyl 7-[(1R,2R,3S)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate | 58717-36-5 | Misoprostol EP Impurity E |
| 37 | Methyl 7-(3-hydroxy-5-oxocyclopenten-1-yl)heptanoate. | 40098-26-8 | Misoprostol EP impurity F |
| 38 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3R)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid. | 35864-81-4 | 15-epi Carboprost |
| 39 | (E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid | 76498-29-8 | trans-Carboprost |
| 40 | 2-Amino-2-(hydroxymethyl)propane-1,3-diol | 77-86-1 | Tromethamine WS |
| 41 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid | 38344-08-0 | Bimatoprost S-Acid |
| 42 | (5Z)-7-((1R,2R,3R,5R)-3,5-Dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoic acid | NA | Bimatoprost R-Acid |
| 43 | 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)- | 1163135-96-3 | 15-Keto Bimatoprost |
| 44 | (5Z)-Methyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate | NA | Bimatoprost Acid Methyl Ester |
| 45 | Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate | 130273-87-9 | Bimatoprost isopropyl ester |
| 46 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide | 1163135-92-9 | 15-epi Bimatoprost ((15R)-Bimatoprost) |
| 47 | ((E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide | 1163135-95-2 | 5.6 TRANS- BIMATOPROST IMPURITY |
| 48 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl) phenoxy] but-1-enyl] cyclopentyl]hept-5-enoic acid | 54276-17-4 | Travoprost Acid |
| 49 | Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxo-4-[3-(trifluoromethyl) phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate | 404830-45-1 | 15-Keto Travoprost |
| 50 | 2-(11-(3-(Dimethylamino) propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)-N-methoxy-N-methylacetamide | NA | Olopatadine impurity |
Suma Laboratories ® All rights reserved.